134 related articles for article (PubMed ID: 11979922)
1. [Advance in the treatment of postmenopausal osteoporosis].
Akazawa K
Nihon Rinsho; 2002 Mar; 60 Suppl 3():298-305. PubMed ID: 11979922
[No Abstract] [Full Text] [Related]
2. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
[No Abstract] [Full Text] [Related]
3. Therapy for osteoporosis.
Gray K
J S C Med Assoc; 2001 Mar; 97(3):114-6. PubMed ID: 11285883
[No Abstract] [Full Text] [Related]
4. [Biochemical markers of bone turnover for treatment of osteoporosis].
Fujiyama K; Kiriyama T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():256-62. PubMed ID: 11979917
[No Abstract] [Full Text] [Related]
5. [Treatment of osteoporosis].
Lakatos P
Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
[No Abstract] [Full Text] [Related]
6. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
Rosa J; Vanuga P; Payer J; Svobodník A
Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
[TBL] [Abstract][Full Text] [Related]
7. Advances in osteoporosis therapy. 2003 update of practical guidelines.
Khan A
Can Fam Physician; 2003 Apr; 49():441-7. PubMed ID: 12729240
[TBL] [Abstract][Full Text] [Related]
8. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
[No Abstract] [Full Text] [Related]
9. [Diagnosis and treatment of postmenopausal osteoporosis].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
[No Abstract] [Full Text] [Related]
10. Clinical practice. Postmenopausal osteoporosis.
Rosen CJ
N Engl J Med; 2005 Aug; 353(6):595-603. PubMed ID: 16093468
[No Abstract] [Full Text] [Related]
11. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
[No Abstract] [Full Text] [Related]
12. [Selective estrogen receptor modulators (SERM's) in postmenopausal women].
Kleiverda G
Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2446-7. PubMed ID: 10608980
[No Abstract] [Full Text] [Related]
13. Preventing osteoporosis in symptomatic postmenopausal women.
Gallagher JC; Levine JP
Menopause; 2011 Jan; 18(1):109-18. PubMed ID: 20661164
[TBL] [Abstract][Full Text] [Related]
14. A review of combination regimens for osteoporosis--prevention and treatment.
Miller E; Kalin MF
Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
[TBL] [Abstract][Full Text] [Related]
15. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
16. [Evidence of raloxifene on postmenopausal osteoporosis].
Okano H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
[No Abstract] [Full Text] [Related]
17. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
Bjarnason NH
Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
[No Abstract] [Full Text] [Related]
18. [Effects of SERMs on bone health. The evaluation of raloxifene treatment for elderly women with osteoporosis using bone turnover markers].
Hasegawa M; Ichimura S; Satomi K
Clin Calcium; 2010 Mar; 20(3):413-20. PubMed ID: 20190372
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of postmenopausal osteoporosis].
Loza E
An Sist Sanit Navar; 2003; 26 Suppl 3():91-8. PubMed ID: 14716361
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of osteoporosis: where are we today?
Maby JI
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S9-12. PubMed ID: 12625633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
